Deutsche Bank’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Deutsche Bank’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,840	Closed	-$147K	–	4749
2021 Q2	$147K	Buy	20,840 +14,281	+218%	+$77K	﹤0.01%	3960
2021 Q1	$39K	Sell	6,559 -5,682	-46%	-$34.4K	﹤0.01%	4292
2020 Q4	$57K	Buy	12,241 +1,829	+18%	+$7.88K	﹤0.01%	4085
2020 Q3	$40K	Buy	10,412 +5,574	+115%	+$112K	﹤0.01%	3979
2020 Q2	$139K	Buy	4,838 +3,161	+188%	+$73.2K	﹤0.01%	3297
2020 Q1	$36K	Buy	1,677 +195	+13%	+$4.43K	﹤0.01%	3700
2019 Q4	$29K	Buy	+1,482	New	+$21.1K	﹤0.01%	4177

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank's STSA Position: Q3 2021 in Review

Deutsche Bank sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2021, closing a stake of 20,840 shares — an estimated $147K sold.

Deutsche Bank first reported a position in STSA in Q4 2019 and held it in 7 quarters. The position peaked at $147K in Q2 2021. 45 funds tracked by Wall St. Rank hold STSA as of Q3 2021.

Deutsche Bank reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 20,840 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $147K.
Deutsche Bank first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
Deutsche Bank's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $147K in Q2 2021.
45 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.